97 related articles for article (PubMed ID: 26446892)
21. [Efficacy and safety of focused ultrasound ablation in treatment of submucosal uterine fibroids].
Wang T; Wang W; Chen WZ; Wang YX; Ye HY; Tang J
Zhonghua Fu Chan Ke Za Zhi; 2011 Jun; 46(6):407-11. PubMed ID: 21781578
[TBL] [Abstract][Full Text] [Related]
22. Intraprocedure contrast enhanced ultrasound: the value in assessing the effect of ultrasound-guided high intensity focused ultrasound ablation for uterine fibroids.
Peng S; Hu L; Chen W; Chen J; Yang C; Wang X; Zhang R; Wang Z; Zhang L
Ultrasonics; 2015 Apr; 58():123-8. PubMed ID: 25627929
[TBL] [Abstract][Full Text] [Related]
23. Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System.
Garza Leal JG; Hernandez Leon I; Castillo Saenz L; Lee BB
J Minim Invasive Gynecol; 2011; 18(3):364-71. PubMed ID: 21545960
[TBL] [Abstract][Full Text] [Related]
24. Uterine Fibroids: Correlation of T2 Signal Intensity with Semiquantitative Perfusion MR Parameters in Patients Screened for MR-guided High-Intensity Focused Ultrasound Ablation.
Kim YS; Lee JW; Choi CH; Kim BG; Bae DS; Rhim H; Lim HK
Radiology; 2016 Mar; 278(3):925-35. PubMed ID: 26313526
[TBL] [Abstract][Full Text] [Related]
25. Feasibility, Safety, and Efficacy of Accurate Uterine Fibroid Ablation Using Magnetic Resonance Imaging-Guided High-Intensity Focused Ultrasound With Shot Sonication.
Xu Y; Fu Z; Yang L; Huang Z; Chen WZ; Wang Z
J Ultrasound Med; 2015 Dec; 34(12):2293-303. PubMed ID: 26518278
[TBL] [Abstract][Full Text] [Related]
26. Cost and reimbursement for three fibroid treatments: abdominal hysterectomy, abdominal myomectomy, and uterine fibroid embolization.
Goldberg J; Bussard A; McNeil J; Diamond J
Cardiovasc Intervent Radiol; 2007; 30(1):54-8. PubMed ID: 17031734
[TBL] [Abstract][Full Text] [Related]
27. Ultrasound-guided percutaneous microwave ablation for symptomatic uterine fibroid treatment--a clinical study.
Zhang J; Feng L; Zhang B; Ren J; Li Z; Hu D; Jiang X
Int J Hyperthermia; 2011; 27(5):510-6. PubMed ID: 21756048
[TBL] [Abstract][Full Text] [Related]
28. Enhancing ablation effects of a microbubble-enhancing contrast agent ("SonoVue") in the treatment of uterine fibroids with high-intensity focused ultrasound: a randomized controlled trial.
Jiang N; Xie B; Zhang X; He M; Li K; Bai J; Wang Z; He J; Zhang L
Cardiovasc Intervent Radiol; 2014 Oct; 37(5):1321-8. PubMed ID: 24549267
[TBL] [Abstract][Full Text] [Related]
29. Uterine fibroids: uterine artery embolization versus abdominal hysterectomy for treatment--a prospective, randomized, and controlled clinical trial.
Pinto I; Chimeno P; Romo A; Paúl L; Haya J; de la Cal MA; Bajo J
Radiology; 2003 Feb; 226(2):425-31. PubMed ID: 12563136
[TBL] [Abstract][Full Text] [Related]
30. High expression of cyclooxygenase-2 in uterine fibroids and its correlation with cell proliferation.
Ke X; Dou F; Cheng Z; Dai H; Zhang W; Qu X; Ding P; Zuo X
Eur J Obstet Gynecol Reprod Biol; 2013 Jun; 168(2):199-203. PubMed ID: 23398724
[TBL] [Abstract][Full Text] [Related]
31. Serum vascular endothelial growth factor165 levels and uterine fibroid volume.
Chen DC; Liu JY; Wu GJ; Ku CH; Su HY; Chen CH
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):317-21. PubMed ID: 15762959
[TBL] [Abstract][Full Text] [Related]
32. MR-guided HIFU treatment of symptomatic uterine fibroids using novel feedback-regulated volumetric ablation: effectiveness and clinical practice.
Ruhnke H; Eckey T; Bohlmann MK; Beldoch MP; Neumann A; Agic A; Hägele J; Diedrich K; Barkhausen J; Hunold P
Rofo; 2013 Oct; 185(10):983-91. PubMed ID: 24490234
[TBL] [Abstract][Full Text] [Related]
33. Uterine fibroids: postsonication temperature decay rate enables prediction of therapeutic responses to MR imaging-guided high-intensity focused ultrasound ablation.
Kim YS; Park MJ; Keserci B; Nurmilaukas K; Köhler MO; Rhim H; Lim HK
Radiology; 2014 Feb; 270(2):589-600. PubMed ID: 24072779
[TBL] [Abstract][Full Text] [Related]
34. Safety and efficacy of sonographically guided high-intensity focused ultrasound for symptomatic uterine fibroids: preliminary study of a modified protocol.
Leung JH; Yu SC; Cheung EC; Wong AS; Tong MM; Ho SS; Leung VY; Ahuja AT
J Ultrasound Med; 2014 Oct; 33(10):1811-8. PubMed ID: 25253828
[TBL] [Abstract][Full Text] [Related]
35. Treatment of uterine fibroid with triptorelin before hysterectomy.
Loong EP; Lo KW
Chin Med J (Engl); 1998 Jan; 111(1):67-70. PubMed ID: 10322658
[TBL] [Abstract][Full Text] [Related]
36. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging.
Zhao WP; Chen JY; Zhang L; Li Q; Qin J; Peng S; Li KQ; Wang ZB; Chen WZ
Eur J Radiol; 2013 Jan; 82(1):e43-9. PubMed ID: 23000188
[TBL] [Abstract][Full Text] [Related]
37. Alternatives to hysterectomy: focus on global endometrial ablation, uterine fibroid embolization, and magnetic resonance-guided focused ultrasound.
Stovall DW
Menopause; 2011 Apr; 18(4):437-44. PubMed ID: 21701430
[TBL] [Abstract][Full Text] [Related]
38. Uterine fibroid pseudocapsule studied by transmission electron microscopy.
Malvasi A; Cavallotti C; Morroni M; Lorenzi T; Dell'Edera D; Nicolardi G; Tinelli A
Eur J Obstet Gynecol Reprod Biol; 2012 Jun; 162(2):187-91. PubMed ID: 22445207
[TBL] [Abstract][Full Text] [Related]
39. The electrical conductivity of in vivo human uterine fibroids.
DeLonzor R; Spero RK; Williams JJ
Int J Hyperthermia; 2011; 27(3):255-65. PubMed ID: 21501027
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of uterine patency following transcervical uterine fibroid ablation with the Sonata system (the OPEN clinical trial).
Bongers M; Quinn SD; Mueller MD; Krämer B; Tuschy B; Sütterlin M; Bassil Lasmar R; Chudnoff S; Thurkow A; De Wilde RL
Eur J Obstet Gynecol Reprod Biol; 2019 Nov; 242():122-125. PubMed ID: 31580964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
